Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Cancer Cell
|
July 14, 2021
I-SPY2 platform: New lessons from the olaparib and durvalumab combination in breast cancer treatment
Jose Perez-Garcia, Maria Gion, Javier Cortes
Molecular Cancer Therapeutics
|
January 11, 2011
Pushing the envelope in the mTOR pathway: the second generation of inhibitors
Eduardo Vilar, Jose Perez-Garcia, Josep Tabernero
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
The effect of biology in the treatment of small breast tumors
Jose Perez-Garcia, Eva Muñoz-Couselo, Javier Cortes
Targeted Oncology
|
November 12, 2009
Targeted therapies in thyroid cancer
Jaume Capdevila, Jose Perez-Garcia, Gabriel Obiols, et al.
NPJ Breast Cancer
|
August 23, 2018
Is there a role for immunotherapy in HER2-positive breast cancer?
Esther Holgado, Jose Perez-Garcia, Maria Gion, et al.
Cancers
|
November 11, 2022
Oligometastatic Disease: When Stage IV Breast Cancer Could Be "Cured"
Maria Gion, Cristina Saavedra, Jose Perez-Garcia, et al.
Current Opinion in Oncology
|
August 30, 2019
Window of Opportunity trials for biomarker discovery in breast cancer
Monica Arnedos, Matthieu Roulleaux Dugage, Jose Perez-Garcia, et al.
Pediatric Emergency Care
|
November 7, 2012
Unexpected diagnosis of severe coarctation of the aorta after ketamine procedural sedation
Maria Jose Perez-Garcia, Raquel Jiménez-Garcia, Ana Siles-Sanchez-Manjavacas
Current Opinion in Cardiology
|
January 8, 2014
An update on mechanical circulatory support for heart failure therapy
Hadi Daood Toeg, Talal Al-Atassi, Jose Perez Garcia, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 2, 2020
Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges
Debora de Melo Gagliato, Antonio C Buzaid, Jose Perez-Garcia, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Cancer Cell
|
July 14, 2021
I-SPY2 platform: New lessons from the olaparib and durvalumab combination in breast cancer treatment
Jose Perez-Garcia, Maria Gion, Javier Cortes
Molecular Cancer Therapeutics
|
January 11, 2011
Pushing the envelope in the mTOR pathway: the second generation of inhibitors
Eduardo Vilar, Jose Perez-Garcia, Josep Tabernero
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
The effect of biology in the treatment of small breast tumors
Jose Perez-Garcia, Eva Muñoz-Couselo, Javier Cortes
Targeted Oncology
|
November 12, 2009
Targeted therapies in thyroid cancer
Jaume Capdevila, Jose Perez-Garcia, Gabriel Obiols, et al.
NPJ Breast Cancer
|
August 23, 2018
Is there a role for immunotherapy in HER2-positive breast cancer?
Esther Holgado, Jose Perez-Garcia, Maria Gion, et al.
Cancers
|
November 11, 2022
Oligometastatic Disease: When Stage IV Breast Cancer Could Be "Cured"
Maria Gion, Cristina Saavedra, Jose Perez-Garcia, et al.
Current Opinion in Oncology
|
August 30, 2019
Window of Opportunity trials for biomarker discovery in breast cancer
Monica Arnedos, Matthieu Roulleaux Dugage, Jose Perez-Garcia, et al.
Pediatric Emergency Care
|
November 7, 2012
Unexpected diagnosis of severe coarctation of the aorta after ketamine procedural sedation
Maria Jose Perez-Garcia, Raquel Jiménez-Garcia, Ana Siles-Sanchez-Manjavacas
Current Opinion in Cardiology
|
January 8, 2014
An update on mechanical circulatory support for heart failure therapy
Hadi Daood Toeg, Talal Al-Atassi, Jose Perez Garcia, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 2, 2020
Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges
Debora de Melo Gagliato, Antonio C Buzaid, Jose Perez-Garcia, et al.
Page
of 3